approval · primary record
DOCOSANOL
FDA · NDA · 2026-04-14
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-04-14 |
| Brand | ABREVA |
| Sponsor | HALEON US HOLDINGS |
| Route | TOPICAL |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:34:13.586Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DOCOSANOL:2026-04-14
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.